RaySearch Laboratories AB (publ) (RAY_B) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

A warm welcome to Research 2025 Year End Results presentation. My name is Karolina Stramblid, and I'm Head of Investor Relations. With me today are our CEO and founder, Johan Lööf, and our CFO, Nina Grønberg, who will take you through the key highlights and financial results. After the presentation, we will open up for questions. Feel free to submit them in the Q&A chat or ask them live. With that said, Johan, over to you. Thank you, Carolina, and welcome again, everyone. So this is the agenda for this webcast. I will start with an interaction about research. Then I will summarize Q4 and the full year. After that, Nina Granberg will talk about the financial development. Then I'll take over again and mention the dividend proposal that we have. Since there is a strong focus on AI these days, I will make a deep dive into what that means for research. And then I will just summarize the presentation and make an outlook. After that, we take Q&A. So, a few words about RaySearch. RaySearch is a pure software company, and we are dedicated to cancer treatment software. And we have four platforms, RayStation, RayCare, RayIntelligence and RayCommand. What we see in this image is a comprehensive cancer center. And our long-term goal is to support such a center with all the software that they need. So not only radiotherapy, but also support for chemotherapy, surgery, tumor board meetings, and other things. So that's the long-term vision for research. So far we have focused mainly on radiation therapy of cancer. What we see in this image is the user interface of RayStation, our treatment planning system. And it summarizes quite well what's going on in treatment planning for radiotherapy. In the upper left, upper, let's see, upper right image here, you see a machine. This particular...